Compare AANJANEYA LIFECARE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS IPCA LABS DR. DATSONS LABS/
IPCA LABS
 
P/E (TTM) x -10.9 23.0 - View Chart
P/BV x 0.2 4.4 3.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   IPCA LABS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
IPCA LABS
Mar-19
DR. DATSONS LABS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1261,042 12.1%   
Low Rs31590 5.2%   
Sales per share (Unadj.) Rs133.0298.6 44.5%  
Earnings per share (Unadj.) Rs0.235.0 0.4%  
Cash flow per share (Unadj.) Rs6.649.4 13.4%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs128.8247.1 52.1%  
Shares outstanding (eoy) m31.66126.35 25.1%   
Bonus/Rights/Conversions FCCBESOS-  
Price / Sales ratio x0.62.7 21.5%   
Avg P/E ratio x516.123.3 2,213.6%  
P/CF ratio (eoy) x11.816.5 71.7%  
Price / Book Value ratio x0.63.3 18.4%  
Dividend payout %08.6 0.0%   
Avg Mkt Cap Rs m2,477103,108 2.4%   
No. of employees `000NA13.4 0.0%   
Total wages/salary Rs m567,874 0.7%   
Avg. sales/employee Rs ThNM2,807.0-  
Avg. wages/employee Rs ThNM585.8-  
Avg. net profit/employee Rs ThNM329.0-  
INCOME DATA
Net Sales Rs m4,21137,732 11.2%  
Other income Rs m79577 13.6%   
Total revenues Rs m4,28938,309 11.2%   
Gross profit Rs m5696,901 8.2%  
Depreciation Rs m2041,824 11.2%   
Interest Rs m430189 228.0%   
Profit before tax Rs m135,465 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,042 0.6%   
Profit after tax Rs m54,422 0.1%  
Gross profit margin %13.518.3 73.8%  
Effective tax rate %48.019.1 251.8%   
Net profit margin %0.111.7 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,85223,778 28.8%   
Current liabilities Rs m6,71110,975 61.1%   
Net working cap to sales %3.333.9 9.9%  
Current ratio x1.02.2 47.1%  
Inventory Days Days161104 155.0%  
Debtors Days Days31866 483.1%  
Net fixed assets Rs m3,67320,368 18.0%   
Share capital Rs m317253 125.3%   
"Free" reserves Rs m3,76130,971 12.1%   
Net worth Rs m4,07831,224 13.1%   
Long term debt Rs m1,6711,409 118.6%   
Total assets Rs m12,63345,507 27.8%  
Interest coverage x1.030.0 3.4%   
Debt to equity ratio x0.40 908.4%  
Sales to assets ratio x0.30.8 40.2%   
Return on assets %3.410.1 34.0%  
Return on equity %0.114.2 0.8%  
Return on capital %7.717.3 44.3%  
Exports to sales %22.945.9 49.9%   
Imports to sales %14.316.6 86.1%   
Exports (fob) Rs m96417,308 5.6%   
Imports (cif) Rs m6026,266 9.6%   
Fx inflow Rs m96417,308 5.6%   
Fx outflow Rs m6076,266 9.7%   
Net fx Rs m35711,042 3.2%   
CASH FLOW
From Operations Rs m1,3454,923 27.3%  
From Investments Rs m-2,256-1,563 144.3%  
From Financial Activity Rs m-1,200-1,832 65.5%  
Net Cashflow Rs m-2,1111,528 -138.2%  

Share Holding

Indian Promoters % 4.5 45.9 9.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 1.4 25.3 5.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.4 540.8%  
Shareholders   20,807 36,892 56.4%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NOVARTIS  TORRENT PHARMA  STRIDES PHARMA SCIENCE  CIPLA  ASTRAZENECA PHARMA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ELDER PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS